clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT03449537 |
P582 | end time | 2020-10-28 | |
P4135 | maximum age | 6 | |
P1050 | medical condition | hypersensitivity | Q5958765 |
P1132 | number of participants | 60 | |
P4844 | research intervention | Caseins in emulsions: interfacial properties and interactions | Q58414129 |
P1813 | short name | SDACMA | |
P580 | start time | 2018-04-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | The Evaluation of the Effects of an Extensive Casein Hydrolysate Containing the Probiotic Lactobacillus Rhamnosus GG as a Possible Step Down Approach Able to Stimulate the Acquisition of Immunological Tolerance Compared to an Amino Acid Formula in Children Affected by Cow's Milk Protein Allergy |